Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Prostate Cancer
 More »

  • AstraZeneca, Janssen to Promote Novel Prostate Cancer Treatment...
    AstraZeneca entered an agreement with Janssen Pharmaceuticals K.K. in Japan to co-promote abiraterone acetate, an oral therapy for the treatment of patients with prostate cancer. ...
    10-11-2013
  • Active Biotech and Hutchison China MediTech Get Rewarded
    The milestone was earmarked for the ongoing 10TASQ10 Phase III trial, which is evaluating tasquinimod in patients with metastatic castrate-resistant prostate cancer who have not ...
    10-9-2013
  • Ovarian Cancer Treatment Options Multiply
    ... CGEN-15049 is expressed in ovarian, lung, breast, colorectal, gastric, prostate, and liver ... with standard-of-care therapies for patients with p53-deficiant ovarian cancer. ...
    10-8-2013
  • J&J's Janssen Companies Launch a Trio of Collaborations
    ... CureVac is currently running a number of clinical trials with its RNActive based vaccines, including a large randomized Phase IIb clinical trial in prostate cancer. The company has ...
    10-3-2013
  • Takeover Targets: Who Is First on the List?
    ... Key products and pipeline: Xtandi® (enzalutamide, formerly MDV3100) capsules for metastatic castration-resistant prostate cancer (mCRPC). Medivation and Astellas Pharma are ...
    9-24-2013
  • Striking Solid Tumors: Transporting Treatments Safely and Effectively
    Delivering efficient drugs into cancer cells in a manner that is safe and effective is ... The most common sites for these tumors are the breast, lung, prostate, colon, brain, ...
    9-23-2013
  • Improve Your Lifestyle, Lengthen Your Telomeres
    For five years, the researchers followed 35 men with localized, early-stage prostate cancer to explore the relationship between comprehensive lifestyle changes, and telomere length ...
    9-17-2013
  • Dendreon Gets Green Light in Europe
    Dendreon said today its prostate cancer drug Provenge® (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) won marketing authorization from ...
    9-17-2013
  • Bruker Launches Second Phase of SISCAPA-MALDI Collaboration
    ... precision for a larger cohort of clinically relevant samples, measuring the endogenous levels of protein C Inhibitor from serum samples of patients treated for prostate cancer. ...
    9-16-2013
  • Roche Signs Up to $422.5M Collaboration with Inovio
    and commercialize the latter's multi-antigen DNA vaccines INO-5150 targeting prostate cancer and INO-1800 targeting hepatitis B. Roche also agreed to license Inovio's ...
    9-10-2013
  • As Big Deals Resurface, Who's Next to the Altar?
    ... with Phase III data for a new indication (polycythemia vera) expected next year; and Medivation successfully launched Xtandi for metastatic castration-resistant prostate cancer. ...
    9-9-2013
  • Cancer Biomarkers: Your Questions Answered
    Razvi: Yes, most of the elements we have provided are not only genes but also proteins-examples being PSA for prostate cancer, CA125 for ovarian cancer-which are both protein ...
    9-9-2013
  • Human Urine Metabolome Study Envisions New Diagnostic Era
    In particular, he notes that new urine-based diagnostic tests for colon cancer, prostate cancer, celiac disease, ulcerative colitis, pneumonia, and organ transplant rejection are ...
    9-6-2013
  • CIRM Approves $40.6M in Early Translational Research Grants
    then advance into clinical trials potential therapies from basic research in prostate cancer, heart disease, liver disease, autism, and HIV/AIDS. The Independent Citizens ...
    8-29-2013
  • Finasteride Cuts Prostate Cancer Risk; No Lifespan Impact
    The generic drug finasteride indeed reduces the risk of prostate cancer in men by at least about one-third, but has no impact on their lifespans, according to results of an 18-year ...
    8-15-2013
  • More »

    Journal Articles

  • Prostate Cancer Proteomics
    John R. Masters
    OMICS: A Journal of Integrative Biology
    Prostate Cancer Proteomics OMICS: A Journal of Integrative Biology Abstract: Proteomics has offered the hope of biomarker discovery to improve the management of prostate cancer. ...
  • Prostate Cancer Proteomics
    John R. Masters
    OMICS: A Journal of Integrative Biology
    Prostate Cancer Proteomics OMICS: A Journal of Integrative Biology Abstract Proteomics has offered the hope of biomarker discovery to improve the management of prostate cancer. ...
  • Prostate Cancer Gene Therapy: Herpes Simplex Virus Thymidine...
    James A. Eastham, Shu-Hsai Chen, Inder Sehgal, Guang Yang, Terry L. Timme, Simon J. Hall, Savio L. C. Woo, Timothy C. Thompson
    Human Gene Therapy and Part B: Methods
    Prostate Cancer Gene Therapy: Herpes Simplex Virus Thymidine Kinase Gene Transduction Followed by Ganciclovir in Mouse and Human Prostate Cancer Models Human Gene Therapy and Part ...
  • Optimizing Prostate Cancer Suicide Gene Therapy Using Herpes...
    Allan J. Pantuck, Jamie Matherly, Amnon Zisman, David Nguyen, Frank Berger, Sanjiv S. Gambhir, Margaret E. Black, Arie Belldegrun, Lily Wu
    Human Gene Therapy and Part B: Methods
    Optimizing Prostate Cancer Suicide Gene Therapy Using Herpes Simplex Virus Thymidine Kinase Active Site Variants Human Gene Therapy and Part B: Methods The herpes simplex virus ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll